Advertisement

Topics

Blogs about Biotechnology, Pharmaceutical and Healthcare

03:18 EST 6th December 2016 | BioPortfolio

Read the latest opinions - blogs from pharmaceutical and life science industry experts.

Showing News Articles 1–25 of 81,000+

Monday 5th December 2016

Des d?fenseurs de la sant? publique du monde entier lancent de nouveaux efforts dans la lutte ...

05 déc. 2016 22h34 HE VIENNE, AUTRICHE--(Marketwired - 5 décembre 2016) -Les efforts visant à contrôler le tabac en tant que menace pour Read more...

Chi-Med Presents Pre-clinical Data for Selective Syk Inhibitor HMPL-523 at the 2016 American ...

Read more...

ABOUND Data Presented at the World Conference on Lung Cancer Further Explores Safety and ...

Interim study findings further support safety, efficacy and tolerability in squamous and elderly patients with advanced NSCLC, consistent with results previously seen in the pivotal Phase III trial Read more...

New Ibrutinib (IMBRUVICA®) Phase 2 Data Demonstrate Promise in Relapsed/Refractory Marginal ...

<iframe src="http://www.multivu.com/players/English/7990431-janssen-oncology-online-press-kit/embed.html" width="512px" height="288px" frameborder="0"></iframe> Read more...

New Phase 2 Data Show Nearly Half of Patients with Relapsed/Refractory Marginal Zone Lymphoma ...

"We are pleased with the 48% response rate seen with ibrutinib in this trial, as the hematology-oncology community has a need for effective new therapies Read more...

Teva Receives Positive Outcome for COPAXONE® Label in Europe

Read more...

App launched to help doctors assess risk of lung cancer in people with lung nodules

Press release A new smartphone app* has been launched today (Tuesday) to help guide doctors on the next steps for patients who have small masses of tissue in their lungs – known as pulmonary nodules. "Moving beyond selfies, social media and playlists, this app is designed to support clinicians in their decision-making so we can help ensure the right people are getting the right tests at the r...

Defensores de Sa?de P?blica de todo o mundo abrem novas frentes na Guerra Contra o Tabaco

VIENNA, AUSTRIA--(Marketwired - 5 de dezembro de 2016) -Os esforços para o controle do tabaco como ameaça à saúde pública intensificaram com a Read more...

Los defensores de la salud p?blica mundial abren nuevos frentes en la guerra contra el tabaco

VIENA, AUSTRIA--(Marketwired - 5 de diciembre de 2016) -Aumentan los esfuerzos por controlar el tabaco como una amenaza a la salud pública al Read more...

American Well Offers Remote Physical Monitoring for Telemedicine Visits

Routine telemedicine visits at the present time are usually restricted to low-intensity patients with the exception of telemedicine as it relates to "remote ICUs" (see: Remote ICUs). Here is a description of remote ICUs from this article: Telemedicine is most commonly used in one-on-one scenarios between a physician and a...

With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill

The U.S. Senate cleared the way for the 21st Century Cures Act, an omnibus healthcare spending and reform bill, by voting 85-13 to end debate this evening. It passed the House with 392 votes last week. After a final Senate vote as early as tomorrow, it will head to President Obama’s desk. The president used […]

Sangamo BioSciences Presents Hemophilia A Program Data At The 2016 American Society Of ...

The development of adenovirus associated vector (AAV) cDNA gene therapy approaches for hemophilia A has been challenging due to a number of factors, including the Read more...

Daratumumab (DARZALEX®) Combination Therapy Showed Consistent Clinical Benefit for ...

<iframe src="http://www.multivu.com/players/English/7990431-janssen-oncology-online-press-kit/embed.html" width="512px" height="288px" frameborder="0"></iframe> Read more...

Brookdale Senior Living (BKD) Investor Presentation - Slideshow

Want to Improve Your Sex Life? Adopt This Personality Trait

New research finds that altruists — those selfless people who care about others — have the best chance of getting lucky with potential sexual partners.

Affinor Growers Installs Second Tower at the Agriculture Research Demonstration Greenhouse ...

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 5, 2016) -Affinor Growers (CSE:AFI)(CSE:AFI.CN)(FRANKFURT:1AF)(OTCQB:RSSFF)("Affinor" or the "Corporation), is pleased to announce it has installed the second vertical Read more...

Arch Therapeutics to Present at 9th Annual LD Micro Main Event on December 7, 2016

FRAMINGHAM, MA--(Marketwired - Dec 5, 2016) - Arch Therapeutics, Inc. ( OTCQB : ARTH) ("Arch" or the "Company"), developer of the AC5™ devices Read more...

Mumps Outbreaks Are Worst in a Decade

The number of mumps cases has nearly tripled in 2016, making it the worst year for outbreaks in a decade. Despite widespread vaccination requirements, college campuses are bearing the brunt of the attack.

Neurocrine Biosciences Announces INGREZZA™ (valbenazine) Long-Term Data to be Presented at ...

"We are pleased to share the positive and compelling long-term treatment data of INGREZZA in tardive dyskinesia patients with the broader scientific community," said Chris Read more...

Crossing State Lines Is No Easy Jaunt for Insurers, Local Regulators

As Republicans gear up to overhaul the federal health law, they face pushback from a couple unexpected corners on one of their goals: Giving health insurers greater ability to sell policies to consumers across state lines.

NexgenRx Announces CFO Changes

NexgenRx Announces CFO Changes

Rare Superbug Gene Found on Pig Farm

Researchers have found a rare, frightening superbug gene on a U.S. pig farm and say their discovery suggests raw meat could carry the dangerous germ.

Aetna and Humana Defend Merger, as Antitrust Trial Begins

The Justice Department and proposed merger partners Aetna Inc. and Humana Inc. presented a judge Monday with starkly different visions of how the transaction would affect the marketplace.

Ogilvy CommonHealth Worldwide wins silver at 2016 Clio Health Awards

PARSIPPANY, NJ--(Marketwired - Dec 5, 2016) - Ogilvy CommonHealth Worldwide ( www.ogilvychww.com), the health behavior change specialists of Ogilvy & Mather ( www.ogilvy.com Read more...

Axovant to Present Patient Function and Independence Data Analyses from Phase 2b Study of ...

Intepirdine is an investigational 5-HT6 receptor antagonist in development as a potential treatment for individuals with Alzheimer's disease on a stable background of donepezil therapy. Read more...


Quick Search
Advertisement